COVID-19 Archives - Page 17 of 22

High Flow Nasal Cannula: A sigh of relief for fragile COVID-19 patients?

bioxone October 23, 2020October 23, 2020

-Sashreek Ganguli, Amity University Kolkata One- fifth of the COVID-19 patients in today’s world develop critical interstitial pneumonia characterized by bilateral interstitial infiltrates, leading to Acute Respiratory Distress Syndrome (ARDS) and respiratory failure. These patients while under treatment show acute hypoxemia and often have persistent dyspnea, despite the administration of oxygen flows>10–15l/min through a facial […]

Is it possible to detect COVID 19 under 15 minutes?

bioxone October 23, 2020October 23, 2020

-Arpita Adhikary, Amity University Kolkata At the University of Technology Sydney, Australia, a rapid antigen test is developed using novel optical technology, iStrip technology is used to measure the saliva even in a very low amount and after 15 minutes result is displayed on the instrument’s small screen. This efficient, quick, and cost-effective ($A25 per […]

Neuropilin-1 (NRP-1) influencing SARS-CoV-2 to infect human cells more abruptly

bioxone October 22, 2020October 22, 2020

Devyani Goswami, Amity University Kolkata The spike proteins of the SARS-CoV-2 have been always the subject of interest in how it attaches to the human cells and causes the disease. Angiotensin-converting enzyme 2 (ACE2) is identified as the functional receptor for SARS-CoV (the virus observed in 2003); they are present in the epithelia of the […]

IVIG:Intravenous Immunoglobulins in the treatment of COVID-19

bioxone October 21, 2020October 21, 2020

Binayak Das, Team Bioxone A study conducted to unravel the potential of immunotherapy for patients affected by the covid-19 virus has announced that treatment with intravenous-immunoglobulin can potentially benefit covid-19 patients that are severely affected. Intravenous immunoglobulin or IVIG is the collection of IgG obtained from the blood serum of a large number of healthy […]

Stem cell-derived human lung organoid model- the next chapter in Viral Disease Research?

bioxone October 20, 2020October 20, 2020

Sampriti Roy, Asutosh College, University of Calcutta SARS-CoV-2, the talk of the town (read “world”), still lacks information related to its origin and exact mechanism. The virus, found to cause DAD (diffuse alveolar damage), leads to respiratory failure which appears to be the common mechanism of death in patients with severe COVID-19 infection. However, with […]

A new strategy for Covid: Targeting TMPRSS2 and ACE2 (Androgenic Regulations)

bioxone October 20, 2020October 20, 2020 1

Anwesha Chatterjee, Amity University Kolkata The novel Corona Virus (SARS-CoV-2) infection which is responsible for the COVID-19 pandemic is expecting an adverse effect on the progression of multiple cancers, i.e. prostate cancer, due to the transpiring cytokine storm associated with oncogenic signalling. Cancer progression can be prevented at an early stage by blocking SARS-COV-2 infection […]

Covid Update: Moderna Vaccine on the Horizon!

bioxone October 20, 2020October 20, 2020

Chitra Roy, University of Calcutta An American biotechnology company ‘Moderna’, based in Cambridge, Massachusetts focuses on the discovery and development of drugs in addition to vaccine technologies. They exclusively use messenger RNA (mRNA) therapeutics and designs vaccines to create a completely new generation of transformative medicines. Against COVID-19, Moderna has developed its mRNA vaccine candidate […]

Is the pandemic interfering with the treatment for other diseases?

bioxone October 19, 2020October 19, 2020

Camelia Bhattacharyya, Amity University Kolkata The pandemic, that is, the COVID-19 pandemic hit the world all of a sudden, changing infection rates or rather increasing it every day without leaving the world to think of the ways to fight with the unknown enemy, the virus. This created a lot of panic at the beginning of […]

Is COVID-19, a bacterium, or a virus?

bioxone October 18, 2020October 18, 2020

Salapu Chandralekha, Amity University Kolkata What secret did the Italian doctors uncover to prove that the COVID-19 is a bacterium, not a virus as advocated by the WHO guidelines? Italy was one of the European Nation’s which bore the brunt of COVID-19 pandemic accounting for over for 7.2% of deaths recorded across the Globe with […]

Are COVID-19 patients diagnosed with Down Syndrome prone to severe diseases?

bioxone October 18, 2020October 18, 2020

Sayak Banerjee, Amity University Kolkata Down syndrome (DS), also known as trisomy 21 is the most persistent aneuploidy characterized by a genetic disorder caused due to the triplication of the 21st human chromosome. This syndrome is particularly associated with the development of congenital heart disease, sleep apnoea, obesity, diabetes, premature ageing, and higher sensitivity to […]

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

High Flow Nasal Cannula: A sigh of relief for fragile COVID-19 patients?

Is it possible to detect COVID 19 under 15 minutes?

Neuropilin-1 (NRP-1) influencing SARS-CoV-2 to infect human cells more abruptly

IVIG:Intravenous Immunoglobulins in the treatment of COVID-19

Stem cell-derived human lung organoid model- the next chapter in Viral Disease Research?

A new strategy for Covid: Targeting TMPRSS2 and ACE2 (Androgenic Regulations)

Covid Update: Moderna Vaccine on the Horizon!

Is COVID-19, a bacterium, or a virus?

Are COVID-19 patients diagnosed with Down Syndrome prone to severe diseases?

Most Viewed This Week

Search Field

Subscribe Now

Breaking News